Articles tagged under: Elanco Animal Health
Growing Gut Health
Published February 16, 2023
Elanco Animal Health Beef Cattle Technical Consultant Frank White says there’s been a new focus on gut health in livestock and a live yeast may be the answer to promoting gut health. "We found that the gut is the first…Vaccination Program Benefits
Published February 15, 2023
A good vaccination program considers a livestock producers’ environment and herd management. An effective vaccination program delivers a positive return-on-investment. "Calves that have been well vaccinated will boost a buyer's confidence and bring a premium," explained Thatch Winslow, beef cattle…Grain Prices Spurs Feed Efficiency
Published February 11, 2023
Elanco Animal Health Tech Service Support Mike Brown says feed prices are spurring livestock producers to adopt new additives quicker. "We have some of the highest grain prices since 2014, so customers have been adapting to the climate to get…Battling Bovine Belching
Published April 27, 2022
Elanco Animal Health is getting the U.S. licensing rights to a feed additive developed by a Dutch company that is supposed to reduce cattle methane emissions. On-farm trials in 14 countries show the additive reduced the greenhouse gas emissions by…Activist Investor Cranks Up Pressure on Ag Companies
Published March 4, 2021
Starboard Value has increased its ownership stake in Elanco Animal Health and nominated three directors to the company’s board. This is the same investor group that nominated eight directors to the Corteva board in January and called for the removal…Job Cuts for Animal Health Company
Published October 1, 2020
Elanco Animal Health is eliminating more than 900 jobs as part of its restructuring after its acquisition of Bayer Animal Health. Company officials said this move will reduce duplication and drive efficiency.Animal Health Deal Nears Completion
Published July 21, 2020
Elanco Animal Health’s purchase of Bayer Animal Health is now going through a 30 day comment period. To move forward with the $7.6 billion deal, Elanco has to divest of a few products. That would include the U.S. rights to…Animal Health Companies Receive Regulatory Approval
Published July 16, 2020
Elanco Animal Health’s acquisition of Bayer Animal Health has received approval from the Federal Trade Commission. Elanco had to divest of some products to gain this approval. The deal with worth $7.6 billion and should be finalized in August.Elanco Spins Off Coccidiosis Product to Merck Animal Health
Published February 20, 2020
Elanco Animal Health has signed an agreement with Merck Animal Health to divest its rights to Vecoxan, which is used to treat coccidiosis in calves and lambs. The all-cash deal totals $55 million. This agreement is contingent on Elanco closing…